Debate on the treatment of multiple sclerosis: Experience from an intractable multiple sclerosis case with rebound syndrome after fingolimod cessation
Sign Up to like & getrecommendations! Published in 2019 at "Clinical and Experimental Neuroimmunology"
DOI: 10.1111/cen3.12504
Abstract: Fingolimod is an effective disease‐modifying drug for relapsing–remitting multiple sclerosis (RRMS), but drug discontinuation might cause rebound syndrome, defined as massive and prolonged exacerbation of MS. We report a case of intractable MS with rebound… read more here.
Keywords: sclerosis; case; fingolimod cessation; syndrome fingolimod ... See more keywords
Clinical activity after fingolimod cessation: disease reactivation or rebound?
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Neurology"
DOI: 10.1111/ene.13694
Abstract: There is debate as to whether the apparent rebound after fingolimod discontinuation is related to the discontinuation itself or whether it is due to the natural course of highly active multiple sclerosis (MS). Our aim… read more here.
Keywords: reactivation rebound; clinical activity; activity fingolimod; fingolimod cessation ... See more keywords